CTC
ARNA

Central Trust Company’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Central Trust Company’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200
Closed -$4K – 1208
2016
Q3 		$4K Buy
+200
New +$3.32K ﹤0.01% 1056

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Central Trust Company's ARNA Position: Q4 2016 in Review

Central Trust Company sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2016, closing a stake of 200 shares — an estimated $4K sold.

Central Trust Company first reported a position in ARNA in Q3 2016 and held it in 1 quarter. The position peaked at $4K in Q3 2016. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • Central Trust Company reported no remaining Arena Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Central Trust Company sold 200 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $4K.
  • Central Trust Company first reported a position in Arena Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Central Trust Company's Arena Pharmaceuticals Inc position peaked at $4K in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on Central Trust Company's 13F filing for Q4 2016, filed 24 Jan 2017.